• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• BL Club
• Smartbuy
• Books
• Gallery

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Hyderabad, Oct. 26

Granules India Ltd’s net profit more than doubled to Rs 6 crore in the second quarter ended September 30, compared with the year-ago period. The total revenue of the Hyderabad-based company increased 18.4 per cent to Rs 96.5 crore. “Increased production across our value chain contributed to our growth, including our PFI unit at Jeedimetla which had substantial increases in capacity utilisation. However, it is our finished dosage sales which showed the most imp rovement (resulting in higher growth in the earnings),” Mr C. Krishna Prasad, Managing Director of Granules India, said in a release. Granules recently started manufacturing finished dosages from a new plant with a capacity of 6 billion tablets a year, scalable to 12 billion tablets.

– Our Bureau

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Copyright © 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line